Charles Leich & Co. v. United States

210 F.2d 901, 45 A.F.T.R. (P-H) 422, 1954 U.S. App. LEXIS 4604
CourtCourt of Appeals for the Seventh Circuit
DecidedFebruary 26, 1954
Docket10898_1
StatusPublished
Cited by4 cases

This text of 210 F.2d 901 (Charles Leich & Co. v. United States) is published on Counsel Stack Legal Research, covering Court of Appeals for the Seventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Charles Leich & Co. v. United States, 210 F.2d 901, 45 A.F.T.R. (P-H) 422, 1954 U.S. App. LEXIS 4604 (7th Cir. 1954).

Opinion

DUFFY, Circuit Judge.

This is an action for a refund of excess profits taxes and interest paid for the fiscal year ended April 30, 1942. The facts were stipulated. The district court found the issues favorable to the government.

The questions presented for determination are: (1) whether for the purpose of computing taxpayer’s invested capital under § 718, Internal Revenue Code, 26 U.S.C.A. § 718, for excess profits tax purposes for the fiscal year ended April 30, 1942, taxpayer’s invested capital should be reduced by the fair market value (as taxpayer contends) or by the cost (as the government contends) of property taxpayer exchanged in prior years for shares of its own stock which it thereafter retired; (2) whether taxpayer’s exchange of common stock of H. A. Woods, Inc. and Gillis Drug Company on January 11, 1932, for stock of Woods-Gillis Corporation was accomplished pursuant to a plan of reorganization as defined in § 112(i)(l) of the Revenue Act of 1932, 1 and that the exchange then made came within the scope of § 112(b)(3) of that Act, 2 so that there would be no recognizable loss to plaintiff on the transaction; and (3) whether the Commissioner correctly allocated taxpayer’s basis on the H. A. Woods, Inc. and Gillis Drug Company common stock as between the WoodsGillis preferred and common stock received on the January 11, 1932, exchange.

Prior to January 1,1926, several members of the Leich family, as a partnership, had conducted a wholesale drug business at Evansville, Indiana, under the firm name Charles Leich and Company. As of January 1, 1926, the partnership acquired all of the capital stock (250 shares par value $100) of H. A. Woods Drug Company, which operated certain retail drug stores in Evansville. In July, 1927, the name of the company purchased was changed to H. A. Woods, Inc.

On September 1, 1928, the partnership was succeeded by a corporation, Charles Leich and Company, the plaintiff herein, which had an authorized capitalization of 2,500 shares of 6% cumulative preferred $100 par value stock, and 15,000 *903 shares of no par value common stock. For the assets of the partnership plaintiff issued 10,000 shares of its common stock. Included in the assets was the common stock of H. A. Woods, Inc. which on September 1, 1928, had a basis in the hands of plaintiff of $204,671.41.

On February 18,1929, plaintiff altered and enlarged its capital structure to 75,-000 shares of common no par value stock, and 5,000 shares of 1% cumulative, Series A or Series B, preferred $100 par value stock. As of March 5, 1929, plaintiff issued 40,000 shares of its new no par common stock in exchange for 10,000 shares of its old no par common stock, and it made sales of its new stock to underwriters, as follows:

12,511 shares common stock.$127,900.00 2,221 shares of series A 7% preferred at par, less discount................. 203,174.00

$331,074.00

The plaintiff used the proceeds thereof in part as follows:

Redemption of 194 shares of its old 6% preferred, then outstanding.........$ 20,176.00

Acquisition of Cline-Vick retail drug stores operated in Illinois............... 183,781.61

Acquisition of Wilhelm Drug Co. retail drug store at Carbondale, Illinois, for cash................ 12,836.19

Liquidation of purchase money obligations upon stock of H. A. Woods, Inc....... 83,535.45

Total ....................$300,327.25

The purchase price of Cline-Vick retail stores was paid for as follows:

Cash, including expenses of acquisition............$103,294.11

482 shares of plaintiff’s 7 % Series A preferred stock. . 48,200.00

3,583 shares of plaintiff’s common stock........... 32,287.50

Total $183,781.61

Previously, in September, 1928, plaintiff had acquired the Van Trees Drug Company store for $7,134.86 and also the Meyer Drug Company store #3 for $7,844.85. In the same month the plaintiff transferred these two stores to H. A. Woods, Inc., as a contribution to the latter’s capital surplus in the sum of $14,979.71.

On or about March 5, 1929, plaintiff transferred to H. A. Woods, Inc. the Cline-Vick stores and the Wilhelm store as contributions to the transferee’s capital surplus. Such contributions were entered in the books of H. A. Woods, Inc., in the same amounts they had previously been entered on plaintiff’s books, viz., Cline-Vick stores, $183,781.61, and Wilhelm store $12,836.19.

As of May 1, 1929, plaintiff acquired the entire issue of 750 shares of common stock, par value $100 per share, of Gillis Drug Company which operated retail drug stores in Terre Haute, Indiana. For this common stock the plaintiff paid $167,938.85. The outstanding preferred stock of Gillis Drug Company (154 shares of the par value of $100 each), was not affected by the plaintiff’s purchase. Plaintiff paid the purchase price as follows:

Cash, a series of notes and legal fees in connection with acquisition ................ $ 97,538.85

704 shares of plaintiff’s 7% Series B preferred stock, par value $100 each............ 70,400.00

$167,938.85

In order to accomplish the purchase of the 750 shares of common stock of Gillis Drug Company, and for other reasons, the plaintiff, at the time of the purchase, sold 10,583 shares of its common stock without par value for $106,787.50.

The operation of the Cline-Vick stores was unprofitable and they were sold on August 15, 1931, by II. A. Woods, Inc. to Cline-Vick Drug Company, a new corporation in which plaintiff had no interest. As consideration Woods received *904 482 shares of plaintiff’s Series A preferred stock, and 8,583 shares of plaintiff's common stock. This stock received by Woods, and then having an aggregate fair market value of $50,000, was immediately turned over to the plaintiff and held by it until December 31, 1931, when it was cancelled.

As of December 31, 1931, the issued and outstanding capital stock of H. A. Woods, Inc., all of which was owned by the plaintiff, consisted of 250 shares of $100 par value common stock, and it was agreed that as of that date it had a basis to plaintiff of $369,011.45.

As of December 31, 1931, the issued and outstanding capital stock of Gillis Drug Company consisted of 154 shares of $100 par value 8% preferred, none of which was owned by plaintiff, and 750 shares of $100 par value common stock having a basis to plaintiff of $167,938.85.

The business affairs of plaintiff and its subsidiaries had been going badly. Plaintiff found increasing sales resistance from its retail customers because of the retail competition of plaintiff’s subsidiaries, and the subsidiaries found it difficult to get reasonable terms from other wholesalers because of their connection with the plaintiff. Plaintiff decided to dispose of its two retail subsidiaries. On December 28, 1931, plaintiff adopted a plan with a view of divesting itself of any common stock interest in the retail drug business.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
210 F.2d 901, 45 A.F.T.R. (P-H) 422, 1954 U.S. App. LEXIS 4604, Counsel Stack Legal Research, https://law.counselstack.com/opinion/charles-leich-co-v-united-states-ca7-1954.